The Beneficial Effect of Lycium barbarum Polysaccharides on Insulin Resistance and Hepatic Glucose Production in Diabetes
Analytical Cellular Pathology · 2025
DOI: 10.1155/ancp/3176140 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Cellular Pathology, 2025. Verfasst von Fengqi Wan und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Second Hospital and Clinical Medical School, Lanzhou University, Lanzhou, China. Hauptthemen laut MEDLINE: Insulin Resistance, Liver, Drugs, Chinese Herbal, Glucose. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gansu Science and Technology Department, Gansu Education Department.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Lycium barbarum polysaccharides (LBP) displays some antidiabetic effects, but the mechanism is partial disclosure of its preventive activities related to insulin signaling and hepatic glucose metabolism. This study investigates the beneficial effect of LBP on insulin resistance and hepatic glucose production (HGP) in 30 mM glucose induced insulin resistant HepG2 cells (IR‐HepG2) and high fat diet/streptozotocin induced diabetic mice. Additionally, the subacute toxicity of 14‐day‐administration of LBP was assessed in C57BL/6 mice. The results showed that LBP effectively reverted the inhibition of protein kinase B (AKT) and glycogen synthase 3 (GSK3) phosphorylation and countered the elevation of reactive oxygen species (ROS) in IR‐HepG2 triggered by 30 mM glucose. Furthermore, LBP prevented the decline of glucose transporter isoform 2 (GLUT2) level in the diabetic mice liver and restored reduced glucose consumption and uptake in IR‐HepG2. LBP also prevented the decrease in glycogen synthase (GYS2) mRNA expression and the reduction of liver glycogen content in diabetes mellitus (DM) mice. Moreover, LBP downregulated the expressions of glucose‐6‐phosphatase (G6Pase) and phosphoenolpyruvate carboxykinase (PEPCK) to inhibit gluconeogenesis, while upregulated the expressions of glucokinase (GK), phosphofructokinase 1 (PFK1) and pyruvate kinase (PK) to activate glycolysis via the AMP‐activated protein kinase (AMPK) signaling pathway in DM mice. No observed toxicity was found in both HepG2 cells and C57BL/6 mice under the tested conditions and doses. These findings suggest that LBP improves insulin sensitivity in high glucose induced IR‐HepG2 and reduces HGP by regulating glucose uptake, glycogen synthesis and gluconeogenic/glycolytic flux. It may serve as a potential therapeutic approach for diabetes treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The Second Hospital and Clinical Medical School, Lanzhou University, Lanzhou, China.
- School of Pharmacy, Lanzhou University, Lanzhou, China.
- Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, China.
ORCID-Profile: Fengqi Wan, Jiong Dang, Shan Huang, Jiao Cai, Yu Lu, Jiaxin Wu, Jing Wang, Liang Ma
Förderung
- Gansu Science and Technology Department
- Gansu Education Department
Zitieren
APA
Wan, F., Dang, J., Huang, S., Cai, J., Lu, Y., Wu, J., Wang, J., & Ma, L. (2025). The Beneficial Effect of Lycium barbarum Polysaccharides on Insulin Resistance and Hepatic Glucose Production in Diabetes. Analytical Cellular Pathology. https://doi.org/10.1155/ancp/3176140
Vancouver
Wan F, Dang J, Huang S, Cai J, Lu Y, Wu J, et al. The Beneficial Effect of Lycium barbarum Polysaccharides on Insulin Resistance and Hepatic Glucose Production in Diabetes. Analytical Cellular Pathology. 2025. doi:10.1155/ancp/3176140
BibTeX
@article{Wan2025,
author = {Wan, Fengqi and Dang, Jiong and Huang, Shan and Cai, Jiao and Lu, Yu and Wu, Jiaxin and Wang, Jing and Ma, Liang},
title = {The Beneficial Effect of Lycium barbarum Polysaccharides on Insulin Resistance and Hepatic Glucose Production in Diabetes},
journal = {Analytical Cellular Pathology},
year = {2025},
doi = {10.1155/ancp/3176140}
}
EUVIMED